Qiagen (QIA) Stock Forecast & Price Target

Compare

9 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

QIA Analyst Ratings

Moderate Buy

6 Buy

9 Hold

0 Sell

Based on 15 analysts giving stock ratings to

Qiagen

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

QIA Stock 12 Month Forecast

Average Price Target

€46.81

▲(13.83% Upside)

Based on 15 Wall Street analysts offering 12 month price targets for Qiagen in the last 3 months. The average price target is €46.81 with a high forecast of €50.73 and a low forecast of €42.27. The average price target represents a 13.83% change from the last price of €41.12.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"35":"€35","39":"€39","43":"€43","47":"€47","51":"€51"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":50.729919,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€50.73</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":46.806805264,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€46.81</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":42.2749325,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€42.27</span>\n  </div></div>","useHTML":true}}],"tickPositions":[35,39,43,47,51],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.065,44.57768607692307,45.090372153846154,45.60305823076923,46.11574430769231,46.628430384615385,47.14111646153846,47.65380253846154,48.166488615384615,48.6791746923077,49.19186076923077,49.704546846153846,50.21723292307693,{"y":50.729919,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.065,44.27590809723077,44.48681619446154,44.6977242916923,44.908632388923074,45.119540486153845,45.330448583384616,45.54135668061538,45.75226477784615,45.96317287507692,46.17408097230769,46.384989069538456,46.59589716676923,{"y":46.806805264,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.065,43.927302499999996,43.789604999999995,43.6519075,43.51421,43.3765125,43.238814999999995,43.1011175,42.96342,42.8257225,42.688024999999996,42.5503275,42.41263,{"y":42.2749325,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":42.729,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.687,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.991,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.609,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.302,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.12,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.825,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.642,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.24,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.812,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.037,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.905,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.065,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€50.73

Average Price Target€46.81

Lowest Price Target€42.27

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Luke Sergott

Barclays

€49.04

Buy

19.27%

Upside

Reiterated

02/20/26

Analysts Are Bullish on These Healthcare Stocks: CG Oncology, Inc. (CGON), Qiagen (QGEN)

Tycho Peterson

Jefferies

€49.89

Buy

21.32%

Upside

Reiterated

02/19/26

Analysts Offer Insights on Healthcare Companies: OrganiGram Holdings (NASDAQ: OGI) and Qiagen (NYSE: QGEN)

Daniel Arias

Stifel Nicolaus

€42.28

Hold

2.82%

Upside

Reiterated

02/18/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Qiagen (NYSE: QGEN) and Foghorn Therapeutics (NASDAQ: FHTX)

Harry Gillis

Berenberg Bank

€46→€50

Buy

21.60%

Upside

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and Humana (NYSE: HUM)

Dan Leonard

UBS

€43.97

Hold

6.93%

Upside

Reiterated

02/09/26

Qiagen: Slower Core Growth and Back-Half-Loaded Targets Keep Risk/Reward Balanced at Hold

Catherine Ramsey Schulte

Robert W. Baird

€40.94→€44.82

Hold

8.99%

Upside

Reiterated

02/06/26

Qiagen price target raised to $53 from $48.42 at BairdQiagen price target raised to $53 from $48.42 at Baird

Patrick B Donnelly

Citi

€46.84→€46.51

Hold

13.10%

Upside

Reiterated

02/06/26

Qiagen price target lowered to $55 from $55.40 at CitiQiagen price target lowered to $55 from $55.40 at Citi

Casey Woodring

J.P. Morgan

€46.51→€50.73

Buy

23.38%

Upside

Reiterated

02/06/26

Qiagen price target raised to $60 from $55 at JPMorganQiagen price target raised to $60 from $55 at JPMorgan

Jan Koch

Deutsche Bank

―

Hold

―

Reiterated

02/06/26

Analysts Conflicted on These Healthcare Names: BridgeBio Pharma (NASDAQ: BBIO), Bristol-Myers Squibb (NYSE: BMY) and Qiagen (NYSE: QGEN)

Andrew Brackmann

William Blair

―

Hold

―

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and Cardinal Health (NYSE: CAH)

Daniel Brennan

TD Cowen

€40.59→€44.82

Hold

8.99%

Upside

Reiterated

02/04/26

Qiagen: Solid Long‑Term Fundamentals but Near‑Term Headwinds Justify Hold Rating

Aisyah Noor

Morgan Stanley

€44.21→€43

Hold

4.57%

Upside

Reiterated

02/02/26

Qiagen price target lowered to EUR 43 from EUR 44.21 at Morgan StanleyQiagen price target lowered to EUR 43 from EUR 44.21 at Morgan Stanley

Jack Meehan

Nephron

€49.89

Hold

21.32%

Upside

Downgraded

01/21/26

Qiagen downgraded to Hold from Buy at Nephron ResearchQiagen downgraded to Hold from Buy at Nephron Research

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

01/21/26

Michael Ryskin

Bank of America Securities

€47.17

Buy

14.72%

Upside

Reiterated

12/15/25

Bank of America Securities Sticks to Their Buy Rating for Qiagen (QGEN)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Luke Sergott

Barclays

€49.04

Buy

19.27%

Upside

Reiterated

02/20/26

Analysts Are Bullish on These Healthcare Stocks: CG Oncology, Inc. (CGON), Qiagen (QGEN)

Tycho Peterson

Jefferies

€49.89

Buy

21.32%

Upside

Reiterated

02/19/26

Analysts Offer Insights on Healthcare Companies: OrganiGram Holdings (NASDAQ: OGI) and Qiagen (NYSE: QGEN)

Daniel Arias

Stifel Nicolaus

€42.28

Hold

2.82%

Upside

Reiterated

02/18/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Qiagen (NYSE: QGEN) and Foghorn Therapeutics (NASDAQ: FHTX)

Harry Gillis

Berenberg Bank

€46→€50

Buy

21.60%

Upside

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and Humana (NYSE: HUM)

Dan Leonard

UBS

€43.97

Hold

6.93%

Upside

Reiterated

02/09/26

Qiagen: Slower Core Growth and Back-Half-Loaded Targets Keep Risk/Reward Balanced at Hold

Catherine Ramsey Schulte

Robert W. Baird

€40.94→€44.82

Hold

8.99%

Upside

Reiterated

02/06/26

Qiagen price target raised to $53 from $48.42 at BairdQiagen price target raised to $53 from $48.42 at Baird

Patrick B Donnelly

Citi

€46.84→€46.51

Hold

13.10%

Upside

Reiterated

02/06/26

Qiagen price target lowered to $55 from $55.40 at CitiQiagen price target lowered to $55 from $55.40 at Citi

Casey Woodring

J.P. Morgan

€46.51→€50.73

Buy

23.38%

Upside

Reiterated

02/06/26

Qiagen price target raised to $60 from $55 at JPMorganQiagen price target raised to $60 from $55 at JPMorgan

Jan Koch

Deutsche Bank

―

Hold

―

Reiterated

02/06/26

Analysts Conflicted on These Healthcare Names: BridgeBio Pharma (NASDAQ: BBIO), Bristol-Myers Squibb (NYSE: BMY) and Qiagen (NYSE: QGEN)

Andrew Brackmann

William Blair

―

Hold

―

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and Cardinal Health (NYSE: CAH)

Daniel Brennan

TD Cowen

€40.59→€44.82

Hold

8.99%

Upside

Reiterated

02/04/26

Qiagen: Solid Long‑Term Fundamentals but Near‑Term Headwinds Justify Hold Rating

Aisyah Noor

Morgan Stanley

€44.21→€43

Hold

4.57%

Upside

Reiterated

02/02/26

Qiagen price target lowered to EUR 43 from EUR 44.21 at Morgan StanleyQiagen price target lowered to EUR 43 from EUR 44.21 at Morgan Stanley

Jack Meehan

Nephron

€49.89

Hold

21.32%

Upside

Downgraded

01/21/26

Qiagen downgraded to Hold from Buy at Nephron ResearchQiagen downgraded to Hold from Buy at Nephron Research

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

01/21/26

Michael Ryskin

Bank of America Securities

€47.17

Buy

14.72%

Upside

Reiterated

12/15/25

Bank of America Securities Sticks to Their Buy Rating for Qiagen (QGEN)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Qiagen

3 Months

xxx

Success Rate

8/14 ratings generated profit

Average Return

+2.42%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +2.42% per trade.

1 Year

Michael RyskinBank of America Securities

Success Rate

10/14 ratings generated profit

Average Return

+4.78%

reiterated a buy rating 2 months ago

Copying Michael Ryskin's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +4.78% per trade.

2 Years

xxx

Success Rate

12/14 ratings generated profit

Average Return

+7.34%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +7.34% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QIA Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, QIA has received 22 Buy Ratings, 17 Hold Ratings, and 0 Sell Ratings. QIA average Analyst price target in the past 3 months is 46.81.

Each month's total comprises the sum of three months' worth of ratings.

QIA Financial Forecast

QIA Earnings Forecast

Next quarter’s earnings estimate for QIA is €0.46 with a range of €0.45 to €0.47. The previous quarter’s EPS was €0.52. QIA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year QIA has Performed in-line its overall industry.

QIA Sales Forecast

Next quarter’s sales forecast for QIA is €423.80M with a range of €422.07M to €426.13M. The previous quarter’s sales results were €456.92M. QIA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year QIA has Performed in-line its overall industry.

QIA Stock Forecast FAQ

What is DE:QIA’s average 12-month price target, according to analysts?

Based on analyst ratings, Qiagen’s 12-month average price target is 46.81.

What is DE:QIA’s upside potential, based on the analysts’ average price target?

Qiagen has 13.83% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Qiagen a Buy, Sell or Hold?

Qiagen has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 9 hold ratings and 0 sell ratings.

What is Qiagen’s share price target?

The average share price target for Qiagen is 46.81. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €50.73 ,and the lowest forecast is €42.27. The average share price target represents 13.83% Increase from the current price of €41.12.

What do analysts say about Qiagen?

Qiagen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of Qiagen?

To buy shares of DE:QIA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Qiagen (QIA) Stock Forecast & Price Target

QIA Analyst Ratings

QIA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Qiagen

QIA Analyst Recommendation Trends

QIA Financial Forecast

QIA Earnings Forecast

QIA Sales Forecast

QIA Stock Forecast FAQ

Detailed List of Analyst Forecasts